TONGRENTANGCM (03613) Announces Board Meeting to Approve 2025 Annual Results and Consider Dividend

Bulletin Express
03/06

Beijing Tong Ren Tang Chinese Medicine Company Limited (TONGRENTANGCM, 03613) has announced that its board of directors will convene on Friday, 20 March 2026. According to the notice, the meeting will address the approval of annual results for the financial year ended 31 December 2025 and discuss the possible declaration of a final dividend.

The announcement also confirms that Yan Han serves as Chairman and Yue Zheng as Vice Chairman. Other executive directors include Wang Chi, and the non-executive director is Feng Li. Independent non-executive directors are Tsang Yok Sing, Jasper, Xu Hong Xi, and Chan Ngai Chi.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10